SIGA Investor Relations Material
Latest events
Q1 2025
SIGA
Access the full event backlog
Slides, Transcripts, and Reports from 13,000 public companies
Latest reports from SIGA Technologies Inc
Access all reports
SIGA Technologies, Inc. is a pharmaceutical company focused on the development and commercialization of countermeasures to address infectious diseases and biological threats. The company specializes in antiviral therapies, with a particular emphasis on treatments for diseases caused by orthopoxviruses, including smallpox. SIGA’s products are primarily used by government agencies and health organizations to strengthen preparedness for potential outbreaks or bioterrorism events. The company is headquartered in New York, New York, and its shares are listed on the NASDAQ.
Key slides for SIGA Technologies Inc
Company Presentation
SIGA Technologies Inc
Company Presentation
SIGA Technologies Inc
Latest articles
)
The Fifteenth Generation: A Conversation with Pietro Gussalli Beretta
An interview with Pietro Gussalli Beretta on how Beretta Holding blends 500 years of tradition with global growth, innovation, and long-term vision.
10 Jul 2025
)
Citadel: Relentless Optimization at Global Scale
From a Harvard dorm to global dominance, this is the story of how Ken Griffin created one of the best-performing hedge funds of all time.
4 Jul 2025
)
David A. Ricks: Eli Lilly's Chairman and CEO
David Ricks built a decades-long career at Eli Lilly, now leading the giant company through a defining moment in its long pharmaceutical history.
3 Jul 2025
Ticker symbol
SIGA
Country
🇺🇸 United States